Skip to main content

PHILADELPHIA CHROMOSOME MOSAICISM DUE TO ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA MIGHT ADVERSELY AFFECT PROGNOSIS AND RESPONSE TO IMATINIB.

Publication ,  Conference
Landstrom, A; Ketterling, R; Knudson, R; Dewald, G; Tefferi, A
Published in: Journal of Investigative Medicine
March 2007

Duke Scholars

Published In

Journal of Investigative Medicine

DOI

ISSN

1081-5589

Publication Date

March 2007

Volume

55

Issue

2

Start / End Page

S349 / S349

Publisher

SAGE Publications

Related Subject Headings

  • General Clinical Medicine
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Landstrom, A., Ketterling, R., Knudson, R., Dewald, G., & Tefferi, A. (2007). PHILADELPHIA CHROMOSOME MOSAICISM DUE TO ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA MIGHT ADVERSELY AFFECT PROGNOSIS AND RESPONSE TO IMATINIB. In Journal of Investigative Medicine (Vol. 55, pp. S349–S349). SAGE Publications. https://doi.org/10.1097/00042871-200703010-00017
Landstrom, A., R. Ketterling, R. Knudson, G. Dewald, and A. Tefferi. “PHILADELPHIA CHROMOSOME MOSAICISM DUE TO ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA MIGHT ADVERSELY AFFECT PROGNOSIS AND RESPONSE TO IMATINIB.” In Journal of Investigative Medicine, 55:S349–S349. SAGE Publications, 2007. https://doi.org/10.1097/00042871-200703010-00017.
Landstrom A, Ketterling R, Knudson R, Dewald G, Tefferi A. PHILADELPHIA CHROMOSOME MOSAICISM DUE TO ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA MIGHT ADVERSELY AFFECT PROGNOSIS AND RESPONSE TO IMATINIB. In: Journal of Investigative Medicine. SAGE Publications; 2007. p. S349–S349.
Landstrom, A., et al. “PHILADELPHIA CHROMOSOME MOSAICISM DUE TO ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA MIGHT ADVERSELY AFFECT PROGNOSIS AND RESPONSE TO IMATINIB.Journal of Investigative Medicine, vol. 55, no. 2, SAGE Publications, 2007, pp. S349–S349. Crossref, doi:10.1097/00042871-200703010-00017.
Landstrom A, Ketterling R, Knudson R, Dewald G, Tefferi A. PHILADELPHIA CHROMOSOME MOSAICISM DUE TO ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA MIGHT ADVERSELY AFFECT PROGNOSIS AND RESPONSE TO IMATINIB. Journal of Investigative Medicine. SAGE Publications; 2007. p. S349–S349.

Published In

Journal of Investigative Medicine

DOI

ISSN

1081-5589

Publication Date

March 2007

Volume

55

Issue

2

Start / End Page

S349 / S349

Publisher

SAGE Publications

Related Subject Headings

  • General Clinical Medicine
  • 3202 Clinical sciences
  • 1103 Clinical Sciences